Stock Events

Stock Events

Health Sciences Acquisitions Corp 2 

$11.5
3
-$1.81-13.6% Friday 21:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
128.94M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.05
-0.03
-0.02
-0
Expected EPS
N/A
Actual EPS
-0.05

Financials

-Profit Margin
Unprofitable
2020
2021
2022
0Revenue
-2.74MNet Income

Analyst Ratings

$15.67Average Price Target
The highest estimate is 20.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSAQ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes in the medical devices and healthcare sector, offering products that could rival Orchestra BioMed's cardiovascular solutions.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a major player in medical devices, including those for cardiovascular health, directly competing with Orchestra BioMed's offerings.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation produces medical devices that compete in the cardiovascular market, similar to Orchestra BioMed's focus.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular space with Orchestra BioMed.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation offers medical devices and equipment that can compete with Orchestra BioMed's product lines in the healthcare sector.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the medical devices sector, potentially overlapping with Orchestra BioMed's market in healthcare solutions.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. provides robotic-assisted surgical devices, competing in the innovative medical device market alongside Orchestra BioMed.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. offers medical devices and pharmaceuticals that could compete with Orchestra BioMed's healthcare solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the healthcare sector, offering a wide range of products that could compete across Orchestra BioMed's portfolio.

About

Finance
Financial Conglomerates
Health Sciences Acquisitions Corporation 2 intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Show more...
CEO
Country
KY
ISIN
KYG4411D1097

Listings

BOATS
BOATS
OBIO.BOATS
XNAS
US
OBIO

0 Comments

Share your thoughts

FAQ

What is Health Sciences Acquisitions Corp 2 stock price today?▼
The current price of HSAQ is $11.5 USD — it has decreased by -13.6% in the past 24 hours. Watch Health Sciences Acquisitions Corp 2 stock price performance more closely on the chart.
What is Health Sciences Acquisitions Corp 2 stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Health Sciences Acquisitions Corp 2 stocks are traded under the ticker HSAQ.
Is Health Sciences Acquisitions Corp 2 stock price growing?▼
HSAQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Health Sciences Acquisitions Corp 2 has showed a +29.9% increase.
What is Health Sciences Acquisitions Corp 2 market cap?▼
Today Health Sciences Acquisitions Corp 2 has the market capitalization of 128.94M
What were Health Sciences Acquisitions Corp 2 earnings last quarter?▼
HSAQ earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Health Sciences Acquisitions Corp 2 revenue for the last year?▼
Health Sciences Acquisitions Corp 2 revenue for the last year amounts to 0 USD.
What is Health Sciences Acquisitions Corp 2 net income for the last year?▼
HSAQ net income for the last year is -2.74M USD.
In which sector is Health Sciences Acquisitions Corp 2 located?▼
Health Sciences Acquisitions Corp 2 operates in the Other sector.
When did Health Sciences Acquisitions Corp 2 complete a stock split?▼
Health Sciences Acquisitions Corp 2 has not had any recent stock splits.